Evidence map›Paper›PMID 42547600›Full record

ReviewAnnals of hematology2026

30 years in service, 1996-2026: Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Oliver A Cornely, Georg Maschmeyer, Wolfgang Hiddemann, Nico Bekaan, Nicola Giesen, Cornelia Lass-Flörl, Sibylle C Mellinghoff, Verena Petzer, Jon Salmanton-García, Michael Sandherr and 8 more

Abstract readHistorical ArticleReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Annals of hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Oliver A CornelyFaculty of Medicine and University Hospital Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Herderstr. 52 , 50931, Cologne, Germany. oliver.cornely@uk-koeln.de.ORCID http://orcid.org/0000-0001-9599-3137
Georg MaschmeyerGerman Society of Hematology and Medical Oncology (DGHO) and Charité University Medicine Berlin, Campus Benjamin Franklin; Department of Hematology, Oncology and Tumor, Charité University Medicine Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0003-2378-2466
Wolfgang HiddemannDepartment of Medicine III, LMU Klinikum, Munich, Germany.
Nico BekaanFaculty of Medicine and University Hospital Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Herderstr. 52 , 50931, Cologne, Germany.ORCID http://orcid.org/0009-0000-0935-7813
Nicola GiesenDepartment of Hematology, Oncology and Palliative Care; Robert Bosch Centre for Tumour Diseases (RBCT), Robert Bosch Hospital, Stuttgart, Germany.ORCID http://orcid.org/0000-0002-9615-2564
Cornelia Lass-FlörlInstitute of Hygiene and Medical Microbiology, ECMM Excellence Diamond Centre of Medical Mycology, Medical University of Innsbruck, Innsbruck, Austria.ORCID http://orcid.org/0000-0002-2946-7785
Sibylle C MellinghoffFaculty of Medicine and University Hospital Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Herderstr. 52 , 50931, Cologne, Germany.ORCID http://orcid.org/0000-0003-3928-2503
Verena PetzerUniversity Hospital of Internal Medicine V Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria.ORCID http://orcid.org/0000-0002-9205-1440
Jon Salmanton-GarcíaFaculty of Medicine and University Hospital Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Herderstr. 52 , 50931, Cologne, Germany.ORCID http://orcid.org/0000-0002-6766-8297
Michael SandherrGerman Society of Hematology and Medical Oncology (DGHO), Berlin, Germany.ORCID http://orcid.org/0000-0002-8845-6656
Enrico SchalkMedical Faculty, Department of Hematology, Oncology, Cell and Radiation Therapy, Otto von Guericke University Magdeburg, Magdeburg, Germany.ORCID http://orcid.org/0000-0003-1892-5098
Xaver SchielMVZ Penzberg - Filialpraxis Weilheim, Weilheim, Germany.
Martin Schmidt-HieberClinic for Hematology, Oncology, Pneumology, Nephrology and Diabetology, Medical University Lausitz - Carl Thiem (MUL-CT), Cottbus, Germany.ORCID http://orcid.org/0000-0002-3071-6945
Danila SeidelFaculty of Medicine and University Hospital Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Herderstr. 52 , 50931, Cologne, Germany.ORCID http://orcid.org/0000-0003-4388-3117
Jannik StemlerFaculty of Medicine and University Hospital Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Herderstr. 52 , 50931, Cologne, Germany.ORCID http://orcid.org/0000-0001-9152-2469
Daniel TeschnerDepartment of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0001-7351-8060
Laura N WaltiDepartment of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.ORCID http://orcid.org/0000-0002-7048-6590
Christina T RiegerHematology Oncology Germering, Landsberger Str. 27, 82110, Germering, Germany. christina.rieger@med.uni-muenchen.de.ORCID http://orcid.org/0009-0005-4334-3403

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Infectious Diseases Working Party (AGIHO) was established in 1996 as one of the subgroups of the German Society of Hematology and Medical Oncology (DGHO). Marking its 30th anniversary this year, the AGIHO reflects on a period of significant achievement and growth. Beyond its core mission of developing evidence-based clinical practice guidelines for the prevention, diagnosis, and management of infections in patients with cancer, the AGIHO has evolved into a vital platform for clinical trials, collaborative research, and postgraduate medical education. To ensure long-term sustainability and foster emerging talent, "Young AGIHO" was launched in 2023. This initiative aims to strengthen networking among early career physicians specializing in hematology and oncology with a strong focus on infectious diseases. The working party has also expanded its geographical footprint by integrating colleagues from Austria and Switzerland, thereby enhancing its international presence. Through the publication of guidelines in high-ranking international journals, AGIHO visibility has increased significantly. Representatives of the working party now serve as experts for scientific and health policy committees both nationally and internationally. As one of the DGHO's largest and most active subgroups, the AGIHO is ideally positioned to address future challenges in the field.

Indexed as

Communicable DiseasesHematologyMedical OncologySocieties, MedicalGermanyHistory, 20th CenturyHistory, 21st CenturyHumansGuidelinesInfectionLeukemiaLymphomaSolid tumorVaccine

Identifiers

PMID42547600
PMCPMC13433463

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.